[go: up one dir, main page]

UY27324A1 - Nuevas sales de napsilato i - Google Patents

Nuevas sales de napsilato i

Info

Publication number
UY27324A1
UY27324A1 UY27324A UY27324A UY27324A1 UY 27324 A1 UY27324 A1 UY 27324A1 UY 27324 A UY27324 A UY 27324A UY 27324 A UY27324 A UY 27324A UY 27324 A1 UY27324 A1 UY 27324A1
Authority
UY
Uruguay
Prior art keywords
napsilate
salts
new
solvates
stereoisomers
Prior art date
Application number
UY27324A
Other languages
English (en)
Inventor
Taylor Lynne
Original Assignee
Astrazeneca Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Astrazeneca Ab filed Critical Astrazeneca Ab
Publication of UY27324A1 publication Critical patent/UY27324A1/es

Links

Classifications

    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07C—ACYCLIC OR CARBOCYCLIC COMPOUNDS
    • C07C309/00—Sulfonic acids; Halides, esters, or anhydrides thereof
    • C07C309/01—Sulfonic acids
    • C07C309/28—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton
    • C07C309/33—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems
    • C07C309/34—Sulfonic acids having sulfo groups bound to carbon atoms of six-membered aromatic rings of a carbon skeleton of six-membered aromatic rings being part of condensed ring systems formed by two rings
    • C07C309/35—Naphthalene sulfonic acids
    • C—CHEMISTRY; METALLURGY
    • C07—ORGANIC CHEMISTRY
    • C07F—ACYCLIC, CARBOCYCLIC OR HETEROCYCLIC COMPOUNDS CONTAINING ELEMENTS OTHER THAN CARBON, HYDROGEN, HALOGEN, OXYGEN, NITROGEN, SULFUR, SELENIUM OR TELLURIUM
    • C07F9/00—Compounds containing elements of Groups 5 or 15 of the Periodic Table
    • C07F9/02—Phosphorus compounds
    • C07F9/28—Phosphorus compounds with one or more P—C bonds
    • C07F9/48—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof
    • C07F9/4808—Phosphonous acids [RP(OH)2] including [RHP(=O)(OH)]; Thiophosphonous acids including [RP(SH)2], [RHP(=S)(SH)]; Derivatives thereof the acid moiety containing a substituent or structure which is considered as characteristic
    • C07F9/4816—Acyclic saturated acids or derivatices which can have further substituents on alkyl

Landscapes

  • Chemical & Material Sciences (AREA)
  • Organic Chemistry (AREA)
  • Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Biochemistry (AREA)
  • General Health & Medical Sciences (AREA)
  • Molecular Biology (AREA)
  • Acyclic And Carbocyclic Compounds In Medicinal Compositions (AREA)
  • Nitrogen Condensed Heterocyclic Rings (AREA)

Abstract

Novedosas sales napsilato de fórmula I, o solvatos de las mismas y estereoisómeros de las mismas, así como también un proceso para la preparación de los mismos, composiciones farmacéuticas que contienen la sal de napsilato terapéuticamente activa y el uso de los mencionados compuestos activos en tratamientos.
UY27324A 2001-06-08 2002-06-07 Nuevas sales de napsilato i UY27324A1 (es)

Applications Claiming Priority (1)

Application Number Priority Date Filing Date Title
SE0102057A SE0102057D0 (sv) 2001-06-08 2001-06-08 New Salts I

Publications (1)

Publication Number Publication Date
UY27324A1 true UY27324A1 (es) 2003-02-28

Family

ID=20284432

Family Applications (1)

Application Number Title Priority Date Filing Date
UY27324A UY27324A1 (es) 2001-06-08 2002-06-07 Nuevas sales de napsilato i

Country Status (3)

Country Link
SE (1) SE0102057D0 (es)
UY (1) UY27324A1 (es)
WO (1) WO2002100869A1 (es)

Families Citing this family (10)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US7494985B2 (en) 2004-11-03 2009-02-24 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis, and use
US7566738B2 (en) 2004-11-03 2009-07-28 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs of sulfinic acids, methods of synthesis, and use
WO2006071186A1 (en) * 2004-12-27 2006-07-06 Astrazeneca Ab Use of gabab receptor agonists
US20060160777A1 (en) * 2004-12-27 2006-07-20 Anders Lehmann New use of GABAbeta receptor agonists
US7585996B2 (en) 2006-09-15 2009-09-08 Xenoport, Inc. Acyloxyalkyl carbamate prodrugs, methods of synthesis and use
CN101743011A (zh) * 2007-07-25 2010-06-16 阿斯利康(瑞典)有限公司 (3-氨基-2-氟丙基)次膦酸用于治疗非糜烂性反流病的用途
EP2235026A4 (en) * 2007-12-21 2011-08-17 Astrazeneca Ab NEW PROCESS FOR THE PREPARATION OF (2R) - (3-AMINO-2-FLUORO-PROPYL) PHOSPHIC ACID FORM A
PE20091176A1 (es) * 2007-12-21 2009-09-03 Astrazeneca Ab Nueva forma cristalina c del acido (2r)-(3-amino-2-fluoropropil)fosfinico
WO2009082345A1 (en) * 2007-12-21 2009-07-02 Astrazeneca Ab Novel crystalline form b of (2r)-(3-amino-2-fluoropropyl)phosphinic acid
US20120016021A1 (en) 2010-07-15 2012-01-19 Xenoport, Inc. Methods of treating fragile x syndrome, down's syndrome, autism and related disorders

Family Cites Families (1)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
SE9603408D0 (sv) * 1996-09-18 1996-09-18 Astra Ab Medical use

Also Published As

Publication number Publication date
SE0102057D0 (sv) 2001-06-08
WO2002100869A1 (en) 2002-12-19

Similar Documents

Publication Publication Date Title
UY27740A1 (es) Nuevos compuestos
UY28510A1 (es) Compuestos quimicos
PA8587101A1 (es) Nuevos derivados de dihidropirimido [4,5-d] pirimidinona sustituida por amiino, fabricacion y uso de los mismos como agentes farmaceuticos
PA8680701A1 (es) Derivados de oxindol
ECSP034774A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP034773A (es) Pirazolopirimmidinas como agentes terapeuticos
ECSP045483A (es) Derivados de heteroarilamida benzocondensada de tienopiridinas útiles como agentes terapéuticos, composiciones farmacéuticas que incluyen a los mismos, y métodos para su uso
ECSP055738A (es) PROCESO ENANTIOSELECTIVO PARA LA PREPARACIÓN DE AMBOS ENANTIÓMEROS DE 10,11-DIHIDRO-10-HIDROXI-5H-DIBENZ-[b,f]-AZEPIN-5-CARBOXAMIDA Y SUS NUEVAS FORMAS DE CRISTAL
ECSP105253A (es) Derivados de 5-feniltiazol y uso como inhibidores de pi3 cinasa
CR8102A (es) Derivados de pirazolo- quinazolina, procedimiento para preparacion y su uso como inhibidores de quinasa
UY27446A1 (es) Nuevos compuestos
AR047070A1 (es) Derivados de difenilazetidona
ECSP088329A (es) Nuevos diazaespiroalcanos y su uso para el tratamiento de enfermedades mediadas por ccr8
PA8432901A1 (es) Compuestos de piridilpirrol
ES2160640T3 (es) Nuevos (r)-5-carbamoil-8-fluoro-3-amino disustituido en n,n-3,4-dihidro-2h-1-benzopiranos.
SE0400043D0 (sv) New compounds
ATE300541T1 (de) Pyrazolopyridinderivate
UY27338A1 (es) Nuevos derivados de ácido sulfónico
UY27685A1 (es) Indolil-urea derivados de tienopiridinas útiles como agentes antiangiogénicos, y procedimientos para su uso
UY27786A1 (es) Derivados de isoquinolina.
AR041340A1 (es) Derivados de tiazolpirimidinona,proceso de preparacion y composiciones farmaceuticas que los contienen
AR018162A1 (es) Pirroles substituidos, composicion farmaceutica y el uso de los mismos para la preparacion de dicha composicion farmaceutica
UY27324A1 (es) Nuevas sales de napsilato i
ES2135722T3 (es) 1,5-benzodiacepinas 5-heterociclicas moduladoras de la cck o de la gastrina.
SE0401655D0 (sv) New compounds

Legal Events

Date Code Title Description
DESI Application deemed to be withdrawn

Effective date: 20111129